Ascolta il podcast Communicable

Communicable E26: SNAP out of it: Rethinking anti-staphylococcal penicillins for S. aureus bacteremia - the SNAP trial PSSA/MSSA results	Communicable	70:50
Communicable E25: The Nightmare Series, part 5 - Measles is back	Communicable	55:27
Communicable E24: The role of medical societies in global health - An interview with ESCMID leadership	Communicable	47:50
Communicable E23: Women & men in medicine: An honest discussion, part 2	Communicable	31:24
Communicable E22: Women & men in medicine: An honest discussion, part 1	Communicable	40:17
Communicable E21: FMT for C. difficile infections - does it work?	Communicable	56:32
Communicable E20: Tuberculosis today	Communicable	54:18
Communicable E19: ‘Super gonorrhoea’ & other sexually transmitted infections	Communicable	58:15
Communicable E18: The Nightmare Series, part 4 - How to manage polio and rubella	Communicable	59:47
Communicable E17: Season’s greetings from the editors & holiday replay of late-breaker clinical trials at ESCMID Global 2024	Communicable	64:39
Communicable E16: Climate change and infections – effects on clinical practice & infection-control efforts	Communicable	50:46
Communicable E15: Wastewater surveillance – can it really protect us from infections?	Communicable	54:59
Communicable E14 - Substandard and falsified antimicrobials: what is their effect on patients and on AMR?	Communicable	52:00
Communicable E13 - The Wild West of publishing today: predatory journals and how to deal with them	Communicable	46:22
Communicable E12 - The Nightmare Series, part 3: How to deal with vancomycin-resistant enterococci	Communicable	57:01
Communicable E11 - Nightmare series, part 2: How to deal with carbapenemase producers	Communicable	60:22
Communicable E10 - Pipeline update: new antibiotics & other antimicrobials that you might actually use	Communicable	52:37
Communicable E9 - Avian flu: an update	Communicable	50:25
Communicable E8 - The Nightmare Series, part 1: How to deal with Candida auris	Communicable	59:24
Communicable E7 - Melioidosis goes global	Communicable	52:08
Communicable E6 - “Sneaky viruses”: an update on hepatitis B & C before World Hepatitis Day	Communicable	54:06
Communicable E5 - Beauty is in the 'I' of the beholder: EUCAST updates	Communicable	38:31
Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice?	Communicable	44:52
Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first?	Communicable	42:58
Communicable E2 - Phage therapy: does it work and will we have access?	Communicable	54:00
Communicable E1 - Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice?	Communicable	58:02

Communicable E26: SNAP out of it: Rethinking anti-staphylococcal penicillins for S. aureus bacteremia - the SNAP trial PSSA/MSSA results

Communicable

70:50

Communicable E25: The Nightmare Series, part 5 - Measles is back

Communicable

55:27

Communicable E24: The role of medical societies in global health - An interview with ESCMID leadership

Communicable

47:50

Communicable E23: Women & men in medicine: An honest discussion, part 2

Communicable

31:24